Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

62 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
The Brazilian TP53 mutation (R337H) and sarcomas.
Volc SM, Ramos CRN, Galvão HCR, Felicio PS, Coelho AS, Berardineli GN, Campacci N, Sabato CDS, Abrahao-Machado LF, Santana IVV, Campanella N, Lengert AVH, Vidal DO, Reis RM, Dantas CF, Coelho RC, Boldrini E, Serrano SV, Palmero EI. Volc SM, et al. Among authors: vidal do. PLoS One. 2020 Jan 24;15(1):e0227260. doi: 10.1371/journal.pone.0227260. eCollection 2020. PLoS One. 2020. PMID: 31978118 Free PMC article.
The role of microRNAs in medulloblastoma.
Vidal DO, Marques MM, Lopes LF, Reis RM. Vidal DO, et al. Pediatr Hematol Oncol. 2013 Aug;30(5):367-78. doi: 10.3109/08880018.2013.783890. Epub 2013 Mar 25. Pediatr Hematol Oncol. 2013. PMID: 23528184 Review.
Hotspot TERT promoter mutations are rare events in testicular germ cell tumors.
Cárcano FM, Vidal DO, van Helvoort Lengert A, Neto CS, Queiroz L, Marques H, Baltazar F, da Silva Martinelli CM, Soares P, da Silva EC, Lopes LF, Reis RM. Cárcano FM, et al. Among authors: vidal do. Tumour Biol. 2016 Apr;37(4):4901-7. doi: 10.1007/s13277-015-4317-y. Epub 2015 Nov 3. Tumour Biol. 2016. PMID: 26526580
High Expression of HULC Is Associated with Poor Prognosis in Osteosarcoma Patients.
Uzan VR, Lengert Av, Boldrini É, Penna V, Scapulatempo-Neto C, Scrideli CA, Filho AP, Cavalcante CE, de Oliveira CZ, Lopes LF, Vidal DO. Uzan VR, et al. Among authors: vidal do. PLoS One. 2016 Jun 2;11(6):e0156774. doi: 10.1371/journal.pone.0156774. eCollection 2016. PLoS One. 2016. PMID: 27253450 Free PMC article.
Insights in Osteosarcoma by Proton Nuclear Magnetic Resonance Serum Metabonomics.
Quintero Escobar M, Costa TBBC, Martins LG, Costa SS, vanHelvoort Lengert A, Boldrini É, Morini da Silva SR, Lopes LF, Vidal DO, Krepischi ACV, Maschietto M, Tasic L. Quintero Escobar M, et al. Among authors: vidal do. Front Oncol. 2020 Oct 16;10:506959. doi: 10.3389/fonc.2020.506959. eCollection 2020. Front Oncol. 2020. PMID: 33178572 Free PMC article.
Potential New Therapeutic Approaches for Cisplatin-Resistant Testicular Germ Cell Tumors.
Lengert AVH, Pereira LDNB, Cabral ERM, Gomes INF, Jesus LM, Gonçalves MFS, Rocha AOD, Tassinari TA, Silva LSD, Laus AC, Vidal DO, Pinto MT, Reis RM, Lopes LF. Lengert AVH, et al. Among authors: vidal do. Front Biosci (Landmark Ed). 2022 Aug 16;27(8):245. doi: 10.31083/j.fbl2708245. Front Biosci (Landmark Ed). 2022. PMID: 36042160 Free article.
62 results